1. Home
  2. ARCB vs RCUS Comparison

ARCB vs RCUS Comparison

Compare ARCB & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ArcBest Corporation

ARCB

ArcBest Corporation

HOLD

Current Price

$144.56

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$28.85

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCB
RCUS
Founded
1923
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.0B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
ARCB
RCUS
Price
$144.56
$28.85
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$122.75
$31.90
AVG Volume (30 Days)
420.0K
1.3M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,657,864,000.00
$247,000,000.00
Revenue This Year
$7.00
N/A
Revenue Next Year
$5.80
$45.62
P/E Ratio
N/A
N/A
Revenue Growth
12.56
N/A
52 Week Low
$59.43
$7.92
52 Week High
$176.69
$28.72

Technical Indicators

Market Signals
Indicator
ARCB
RCUS
Relative Strength Index (RSI) 50.38 69.69
Support Level $112.62 $19.78
Resistance Level $176.69 N/A
Average True Range (ATR) 7.84 1.52
MACD -3.22 0.57
Stochastic Oscillator 11.68 88.14

Price Performance

Historical Comparison
ARCB
RCUS

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: